The Part Where Enthusiasm Meets Reality and Reality Wins A pitch deck. A sales rep you hired three weeks ago. A pricing slide that got thrown together the night before a board meeting. A VP of Commercial who starts next month. A shiny new logo the leadership team spent four months arguing about. And, naturally, a LinkedIn post announcing your FDA clearance with enough fire emojis to trigger a smoke alarm. Congratulations. According to a shocking number of MedTech startups, yo

FDA clearance is not the same thing as commercial readiness. In Step 1 of the MedTech Recovery Program, we break down why clinical data, KOL strategy, study design, and early site selection often fail to translate into real U.S. adoption. Learn how successful MedTech companies build commercially relevant evidence before entering hospital systems, Value Analysis Committees, and skeptical physician workflows.